How Thorazine (Chlorpromazine) Works
Thorazine works primarily as a dopamine antagonist at subcortical levels of the central nervous system, producing psychotropic, sedative, and antiemetic effects through actions on multiple neurotransmitter systems. 1
Mechanism of Action
Primary Pharmacological Actions
Chlorpromazine exerts its therapeutic effects through actions at all levels of the CNS, primarily at subcortical levels, though the precise mechanism of its therapeutic effects is not fully elucidated 1. The drug functions as:
- Potent dopamine antagonist - This is the primary mechanism underlying its antipsychotic properties 2
- Strong antiadrenergic activity (alpha-adrenergic blockade) 1
- Weaker peripheral anticholinergic activity 1
- Slight ganglionic blocking action 1
- Slight antihistaminic and antiserotonin activity 1
Receptor-Level Activity
Research demonstrates that chlorpromazine binds to D-2 dopamine receptors in striatal tissue, with the parent compound showing greater binding affinity than its metabolites 2. The drug also exhibits antimuscarinic and anti-alpha-noradrenergic activity, with metabolites showing diverse pharmacologic activities that may differ substantially from the parent compound 3.
Additional Mechanisms
Beyond neurotransmitter modulation, chlorpromazine:
- Inhibits voltage-sensitive calcium channels (alpha1E subunit-mediated), with greater inhibition at more negative membrane potentials 4
- Inhibits Na+-K+-ATPase pumping, which affects cellular sodium gradients and sodium-dependent transport 5
- Inhibits cholinergic transmission through both presynaptic and postsynaptic mechanisms 6
- Inhibits calcium signaling through multiple sites, including muscarinic receptors and store-operated calcium entry 7
Clinical Dosing Reference
For context, chlorpromazine serves as the standard reference for antipsychotic dosing equivalency, with 600 mg/day used as the minimum therapeutic dose threshold in treatment-resistant schizophrenia guidelines 8.
Important Caveats
The drug's CNS depressant effects prolong and intensify other CNS depressants (anesthetics, barbiturates, narcotics), requiring dose reduction of concomitant agents to approximately 1/4 to 1/2 usual dosage 1. Additionally, chlorpromazine elevates prolactin levels persistently during chronic administration, though the clinical significance remains unclear for most patients 1.